Zoono Group (ZOONF) Fair Value & Analysis
Consumer Defensive · US · Market cap $18.2M
Fair value as of: Jun 26, 2026
Analysis
Zoono Group (ZOONF) currently trades at $0.0445, while our model-based Fair Value estimate is $0.0825 — implying the stock looks roughly 85.5% undervalued today. We read business quality at 95/100 (high quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.
About the company
Zoono Group Limited, together with its subsidiaries, engages in the research, development, and sale of a range of antimicrobial products in New Zealand, Australasia, Asia, the United States, India, the United Kingdom, and Europe. It offers hand and surface sanitisers, textile applicator, and mould remediation products. Zoono Group Limited was founded in 2007 and is headquartered in Auckland, New Zealand.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Zoono Group (ZOONF) undervalued?
What is the fair value of ZOONF?
What is the quality score of ZOONF?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.